TY - JOUR
T1 - Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit
AU - Huapaya, Julio A.
AU - Wilfong, Erin M.
AU - Harden, Christopher T.
AU - Brower, Roy G.
AU - Danoff, Sonye K.
N1 - Funding Information:
Support statement: This study was supported by the Lisa Sandler Spaeth Fund for Pulmonary Fibrosis. The sponsor had no role on the conception of this work.
Publisher Copyright:
©ERS 2018.
PY - 2018
Y1 - 2018
N2 - Data on interstitial lung disease (ILD) outcomes in the intensive care unit (ICU) is of limited value due to population heterogeneity. The aim of this study was to examine risk factors for mortality and ILD mortality rates in the ICU. We performed a systematic review using five databases. 50 studies were identified and 34 were included: 17 studies on various aetiologies of ILD (mixed-ILD) and 17 on idiopathic pulmonary fibrosis (IPF). In mixed-ILD, elevated APACHE score, hypoxaemia and mechanical ventilation are risk factors for mortality. No increased mortality was found with steroid use. Evidence is inconclusive on advanced age. In IPF, evidence is inconclusive for all factors except mechanical ventilation and hypoxaemia. The overall in-hospital mortality was available in 15 studies on mixed-ILD (62% in 2001–2009 and 48% in 2010–2017) and 15 studies on IPF (79% in 1993–2004 and 65% in 2005–2017). Follow-up mortality rate at 1 year ranged between 53% and 100%. Irrespective of ILD aetiology, mechanical ventilation is associated with increased mortality. For mixed-ILD, hypoxaemia and APACHE scores are also associated with increased mortality. IPF has the highest mortality rate among ILDs, but since 1993 the rate appears to be declining. Despite improving in-hospital survival, overall mortality remains high.
AB - Data on interstitial lung disease (ILD) outcomes in the intensive care unit (ICU) is of limited value due to population heterogeneity. The aim of this study was to examine risk factors for mortality and ILD mortality rates in the ICU. We performed a systematic review using five databases. 50 studies were identified and 34 were included: 17 studies on various aetiologies of ILD (mixed-ILD) and 17 on idiopathic pulmonary fibrosis (IPF). In mixed-ILD, elevated APACHE score, hypoxaemia and mechanical ventilation are risk factors for mortality. No increased mortality was found with steroid use. Evidence is inconclusive on advanced age. In IPF, evidence is inconclusive for all factors except mechanical ventilation and hypoxaemia. The overall in-hospital mortality was available in 15 studies on mixed-ILD (62% in 2001–2009 and 48% in 2010–2017) and 15 studies on IPF (79% in 1993–2004 and 65% in 2005–2017). Follow-up mortality rate at 1 year ranged between 53% and 100%. Irrespective of ILD aetiology, mechanical ventilation is associated with increased mortality. For mixed-ILD, hypoxaemia and APACHE scores are also associated with increased mortality. IPF has the highest mortality rate among ILDs, but since 1993 the rate appears to be declining. Despite improving in-hospital survival, overall mortality remains high.
UR - http://www.scopus.com/inward/record.url?scp=85056972326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056972326&partnerID=8YFLogxK
U2 - 10.1183/16000617.0061-2018
DO - 10.1183/16000617.0061-2018
M3 - Review article
C2 - 30463873
AN - SCOPUS:85056972326
SN - 0905-9180
VL - 27
JO - European Respiratory Review
JF - European Respiratory Review
IS - 150
M1 - 180061
ER -